Polaris Group (TPE:6550)
Taiwan · Delayed Price · Currency is TWD 35.50
-0.30 (-0.84%)
Oct 28, 2025, 1:35 PM CST
Polaris Group Market Cap
Polaris Group has a market cap or net worth of 27.35 billion as of October 28, 2025. Its market cap has decreased by -32.45% in one year.
Market Cap
27.35B
Enterprise Value
29.47B
Revenue
64.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
35.50
Market Cap Chart
Since February 15, 2016, Polaris Group's market cap has decreased from 46.46B to 27.35B, a decrease of -41.13%. That is a compound annual growth rate of -5.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 27.58B | -19.03% |
| Dec 31, 2024 | 34.06B | -39.39% |
| Dec 29, 2023 | 56.21B | -14.57% |
| Dec 30, 2022 | 65.79B | 24.20% |
| Dec 30, 2021 | 52.97B | 373.09% |
| Dec 31, 2020 | 11.20B | -8.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 252.82B |
| PharmaEssentia | 186.03B |
| Bora Pharmaceuticals Co., LTD. | 77.82B |
| Lotus Pharmaceutical | 74.82B |
| Lumosa Therapeutics | 47.00B |
| Oneness Biotech | 30.13B |
| Center Laboratories | 25.76B |
| Pegavision | 24.84B |